Presence at Facility. Upon at least [c.i.] prior written notice given by DUSA to NBC, DUSA shall have the right to assign a reasonable number of employees or consultants of DUSA to inspect and audit the Facility at which Light Sources are manufactured in order to verify NBC's compliance with QS and other agreed requirements, provided, however that (i) such employees or consultants shall not unreasonably interfere with other activities being carried out at the Facility, (ii) that such employees or consultants shall observe all rules and regulations applicable to visitors and to individuals employed at the Facility, and (iii) such employees or consultants agree to maintain the Confidential Information of NBC in accordance with Article 11 below.
Presence at Facility. During the term of this Agreement, Thermage shall have the right upon reasonable notice and during normal business hours to have its representatives visit the facilities at which Products are being manufactured, and to inspect such facilities and the records relating to the manufacture of Products to verify Stellartech’s compliance with the terms of this Agreement and the warranties in Article 8 below, including Stellartech’s manufacture of Products in compliance with Good Manufacturing Practices (“GMP”), ISO 9000 requirements, or other applicable rules and regulations.
Presence at Facility. SAVIENT shall have the right, from time to time, to assign a reasonable number of its employees or representatives to visit NOF’s manufacturing facility and any other relevant location (e.g. warehouse) for two (2) days per Year (or such other period as may be agreed by the Parties in the event that any material non-compliance with the terms of this Agreement or in the manufacture of the Activated PEG is discovered) in order to inspect, discuss and review the activities performed by NOF under this Agreement and to verify NOF’s compliance with the warranties in ARTICLE 5 with respect to the Activated PEG. The presence of SAVIENT’s employees or representatives shall in no way relieve NOF of any of its obligations under this Agreement.
Presence at Facility. Upon at least fifteen (15) days’ prior written notice given by NeurogesX to CPL, NeurogesX shall have the right to assign a reasonable number of employees or consultants of NeurogesX (not to exceed three (3) persons) to inspect and audit the Facility in order to verify CPL’s compliance with Regulatory Requirements and other agreed requirements. At all times, NeurgoesX personnel or consultants will be accompanied by CPL representatives and access will be limited to areas and documentation applicable to NeurogesX Product or Proposals.
Presence at Facility. During the first six (6) months during which each Product is commercially manufactured for Symyx and thereafter upon reasonable written notice to Argonaut, Symyx shall have the right to have its representatives visit, from time to time, each facility at which such Product is being manufactured, to verify Argonaut's compliance with the Quality Assurance program outlined in Section 7.1.
Presence at Facility. During the term of this Agreement, Somnus shall -------------------- have the right upon reasonable notice and during normal business hours to have its representatives visit the facilities at which Products are being manufactured, and to inspect such facilities and the records relating to the manufacture of Products to verify Apical's compliance with the terms of this Agreement and the warranties in Article 10 below, including Apical's manufacture of Products in compliance with Good Manufacturing Practices ("GMP"), ISO 9000 requirements or other applicable rules and regulations.
Presence at Facility. Upon reasonable notice given by Vivus to Spolana and at reasonable frequency, Vivus shall have the right to assign a reasonable number of employees or consultants of Vivus to inspect and audit the Facility at which Product is manufactured in order to verify Spolana's compliance with the current GMP and other agreed requirements, provided, however that (a) such employees or consultants shall not unreasonably interfere with other activities being carried out at the Facility, and (b) that such employees or consultants shall observe all rules and regulations applicable to visitors and to individuals employed at the Facility. It is understood that as of the Effective Date Vivus has engaged Forum (Holdings) Limited ("Forum") pursuant to that certain agreement dated September 26, 1996 pursuant to which Forum agreed to assist Vivus in ensuring, by aiding Spolana, that Spolana meets and maintains current GMP and requirements necessary for the sale of Product throughout the world.
Presence at Facility. CREALTA shall have the right, from time to time, to assign a reasonable number of its employees or representatives to visit NOF’s manufacturing facility and any other relevant location (e.g. warehouse) for […***…] days per Year (or such other period as may be agreed by the Parties in the event that any material non-compliance with the terms of this Agreement or in the manufacture of the Activated PEG is discovered) in order to inspect, discuss and review the activities performed by NOF under this Agreement and to verify NOF’s compliance with the warranties in ARTICLE 5 with respect to the Activated PEG. The presence of CREALTA’s employees or representatives shall in no way relieve NOF of any of its obligations under this Agreement. ARTICLE 5 WARRANTIES AND LIABILITY ***Confidential Treatment Requested
Presence at Facility. During the first six (6) months during which each Product is commercially manufactured for Urosurge and thereafter upon reasonable written notice to ITC, Urosurge shall have the right to have its representatives visit, from time to time, the facility at which such Product is being manufactured, to verify ITC's compliance with the warranties in Section 10 below.
Presence at Facility. During the term of this Agreement, ACS shall have the right from time to time to have a reasonable number of representatives of ACS selected by ACS to be present at the Prima Pharm facilities at which Products are being manufactured; provided, however, that such representatives shall (i) not interfere in the other activities being carried out at the facility, and (ii) observe all rules and regulations applicable to individuals employed at the facility. The presence of ACS's representative(s) shall in no way relieve Prima Pharm of any of its obligations under this Agreement.
